Xtx Topco LTD Bio Xcel Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.3 Billion
- Q3 2024
A detailed history of Xtx Topco LTD transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 10,710 shares of BTAI stock, worth $4,926. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,710
Previous 46,503
76.97%
Holding current value
$4,926
Previous $59,000
89.83%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding BTAI
# of Institutions
55Shares Held
3.14MCall Options Held
22.2KPut Options Held
40.2K-
Vanguard Group Inc Valley Forge, PA1.2MShares$552,6330.0% of portfolio
-
Black Rock Inc. New York, NY441KShares$202,7150.0% of portfolio
-
Geode Capital Management, LLC Boston, MA298KShares$137,0990.0% of portfolio
-
Wells Fargo & Company San Francisco, CA185KShares$85,1260.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny130KShares$59,7390.0% of portfolio
About BioXcel Therapeutics, Inc.
- Ticker BTAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,022,500
- Market Cap $12.9M
- Description
- BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...